Hints and tips:
Related Special Reports
...“Having a broken leg didn’t make me a lesser person, but it did dictate my immediate actions and greatly limited my options in the moment,” the 57-year-old said on Tuesday....
...The practice is currently limited to a small number of companies, including Illumina and Allelica, and its use is not yet widespread....
...“Big Pharma endorsing Amazon as a distribution partner bolsters Amazon’s role in healthcare and could be the start of many more of these arrangements.”...
...Under the proposed reforms, Medicare, the US taxpayer-funded healthcare scheme for retirees, would be allowed to negotiate prices for a limited number of branded medicines....
...Lex this week opined on three separate pharma outliers praying for rescues from their “lab rats” — as medical researchers sometimes call themselves....
...Much of Big Pharma’s warnings may be scaremongering. The Medicare programme is limited to wildly popular drugs that have already earned back their development costs many times over....
...People working for the companies involved said there was only limited opportunity for serious exchanges....
...The company said on Monday that the drug would be introduced to the UK “through a controlled and limited launch”....
...US pharma giant Eli Lilly is also expanding supplies of its weight loss drug Mounjaro, which the UK approved in November. Supply shortages are not limited to the UK....
...Rare diseases, once ignored, are now vitally important to the pharma sector. Financial incentives have transformed the economics of niche treatments....
...Videos show consumers stampeding through stores to get limited-edition versions of the cup and owners flaunting their collections....
...For several years, investors have been concerned about the relative weakness of the group’s drug development pipeline compared with its peers in big pharma....
...Brussels has limited ability to act but the commission said the proposals contained “sufficient flexibility to target specific vulnerabilities, including problematic dependencies”....
...Yet Europe’s IPO market remains in the doldrums, with investor appetite limited by growing concerns of slowing economic growth....
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
...It makes no commercial sense to invest heavily in drugs whose time on the market will be limited....
...The same complaints can be heard across the innovation industries, including medtech and pharma....
...That limited the downside but also constrained mPharma since, to avoid any conflicts of interest, it would not be able to provide medicines itself....
...Need to know: UK and Europe economy UK chancellor Jeremy Hunt’s hopes of offering big pre-election tax cuts have hit a snag: internal Treasury forecasts suggest he will have only limited scope for giveaways...
...Ninety-five per cent of members said they expected to develop fewer new uses for medicines because of the limited time available before government price setting occurs....
...“If big pharma retreats to places like southern Ireland it puts my business at a competitive disadvantage to one inside the EU,” he said....
...Yet despite a 2014 partnership with US pharma company AbbVie, extended in 2021, Calico has yet to bring any drugs to the market....
...Barriers to M&A are going to make it harder for pharma companies to replenish drug pipelines. The tech sector faces the same issue....
...Pfizer’s chief executive Albert Bourla said the pharma group was “deploying its financial resources to advance the battle against cancer”....
...But EU approval is limited comfort for companies such as Amazon, Google, Meta and Microsoft: the emerging Anglo-American approach to competition enforcement is a feisty enough alternative....
International Edition